Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism Kv1.3 blockers(Voltage-gated potassium channel subunit Kv1.3 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | HU | 01 May 2022 |